Caribou Biosciences
CRBU
CRBU
132 hedge funds and large institutions have $93.1M invested in Caribou Biosciences in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 128 → 132 (+4)
10% less capital invested
Capital invested by funds: $103M → $93.1M (-$10M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
132
Holding in Top 10
1
Calls
$240K
Puts
$176K
Top Buyers
| 1 | +$3.28M | |
| 2 | +$2.47M | |
| 3 | +$1.92M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$744K |
| 5 |
Two Sigma Advisers
New York
|
+$662K |
Top Sellers
| 1 | -$4.45M | |
| 2 | -$1.76M | |
| 3 | -$1.16M | |
| 4 |
BlackRock
New York
|
-$1.06M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$684K |